MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Beth Israel Deaconess Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Eli Lilly and Company
OncoC4, Inc.
National Institutes of Health Clinical Center (CC)
International Agency for Research on Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Institut Paoli-Calmettes
Arcus Biosciences, Inc.
Taiho Oncology, Inc.
RAND
Atavistik Bio, Inc
University of Kansas Medical Center
M.D. Anderson Cancer Center
Sun Yat-sen University
University Health Network, Toronto
University Health Network, Toronto
Duke University
M.D. Anderson Cancer Center
Ascendis Pharma A/S
Qurient Co., Ltd.
Institut du Cancer de Montpellier - Val d'Aurelle
Institute of Cancer Research, United Kingdom
AbbVie
AstraZeneca
National Institutes of Health Clinical Center (CC)
University Ghent
University of Oklahoma
Jonsson Comprehensive Cancer Center
University of Kansas Medical Center
City of Hope Medical Center
Indiana University
University of Rochester
ImmunityBio, Inc.
Beth Israel Deaconess Medical Center
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Huazhong University of Science and Technology
Brigham and Women's Hospital
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Seagen Inc.
National Cancer Institute (NCI)
Université de Sherbrooke